Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Implementation of web-based hospital specialist consultations to improve quality and expediency of general practitioners' care: a feasibility study.

van der Velden T, Schalk BWM, Harmsen M, Adriaansens G, Schermer TR, Ten Dam MA.

BMC Fam Pract. 2019 May 29;20(1):73. doi: 10.1186/s12875-019-0960-5.

2.

The Clinical Course of Minimal Change Nephrotic Syndrome With Onset in Adulthood or Late Adolescence: A Case Series.

Maas RJ, Deegens JK, Beukhof JR, Reichert LJ, Ten Dam MA, Beutler JJ, van den Wall Bake AWL, Rensma PL, Konings CJ, Geerse DA, Feith GW, Van Kuijk WH, Wetzels JF.

Am J Kidney Dis. 2017 May;69(5):637-646. doi: 10.1053/j.ajkd.2016.10.032. Epub 2017 Jan 12.

PMID:
28089478
3.

Evaluation of the Antioxidant Activity of the Marine Pyrroloiminoquinone Makaluvamines.

Alonso E, Alvariño R, Leirós M, Tabudravu JN, Feussner K, Dam MA, Rateb ME, Jaspars M, Botana LM.

Mar Drugs. 2016 Oct 27;14(11). pii: E197.

4.

Dispersed fringe sensor for the Giant Magellan Telescope.

van Dam MA, McLeod BA, Bouchez AH.

Appl Opt. 2016 Jan 20;55(3):539-47. doi: 10.1364/AO.55.000539.

PMID:
26835929
5.

Are the current guidelines on contrast-induced nephropathy prevention superfluous?

ten Dam MA, Wetzels JF.

Neth J Med. 2015 Jan;73(1):45. No abstract available.

6.

ALIDA-II: An Improved Disclosure Scale.

van Dam MA.

J Homosex. 2015;62(10):1313-28. doi: 10.1080/00918369.2015.1060052. Epub 2015 Jun 14.

PMID:
26072964
7.

Nurse practitioner care improves renal outcome in patients with CKD.

Peeters MJ, van Zuilen AD, van den Brand JA, Bots ML, van Buren M, Ten Dam MA, Kaasjager KA, Ligtenberg G, Sijpkens YW, Sluiter HE, van de Ven PJ, Vervoort G, Vleming LJ, Blankestijn PJ, Wetzels JF.

J Am Soc Nephrol. 2014 Feb;25(2):390-8. doi: 10.1681/ASN.2012121222. Epub 2013 Oct 24.

8.

Differences between hospitals in attainment of parathyroid hormone treatment targets in chronic kidney disease do not reflect differences in quality of care.

Peeters MJ, van Zuilen AD, van den Brand JA, Blankestijn PJ, ten Dam MA, Wetzels JF.

BMC Nephrol. 2012 Aug 6;13:82. doi: 10.1186/1471-2369-13-82.

9.

Multifactorial intervention with nurse practitioners does not change cardiovascular outcomes in patients with chronic kidney disease.

van Zuilen AD, Bots ML, Dulger A, van der Tweel I, van Buren M, Ten Dam MA, Kaasjager KA, Ligtenberg G, Sijpkens YW, Sluiter HE, van de Ven PJ, Vervoort G, Vleming LJ, Blankestijn PJ, Wetzels JF.

Kidney Int. 2012 Sep;82(6):710-7. doi: 10.1038/ki.2012.137. Epub 2012 Jun 27.

10.

Nurse practitioners improve quality of care in chronic kidney disease: two-year results of a randomised study.

van Zuilen AD, Blankestijn PJ, van Buren M, ten Dam MA, Kaasjager KA, Ligtenberg G, Sijpkens YW, Sluiter HE, van de Ven PJ, Vervoort G, Vleming L, Bots ML, Wetzels JF.

Neth J Med. 2011 Nov-Dec;69(11):517-26.

11.

Decitabine immunosensitizes human gliomas to NY-ESO-1 specific T lymphocyte targeting through the Fas/Fas ligand pathway.

Konkankit VV, Kim W, Koya RC, Eskin A, Dam MA, Nelson S, Ribas A, Liau LM, Prins RM.

J Transl Med. 2011 Nov 7;9:192. doi: 10.1186/1479-5876-9-192.

12.

Hospital specific factors affect quality of blood pressure treatment in chronic kidney disease.

van Zuilen AD, Blankestijn PJ, van Buren M, Ten Dam MA, Kaasjager KA, Ligtenberg G, Sijpkens YW, Sluiter HE, van de Ven PJ, Vervoort G, Vleming L, Bots ML, Wetzels JF.

Neth J Med. 2011 May;69(5):229-36.

13.

Nephrotic syndrome induced by pamidronate.

ten Dam MA, Hilbrands LB, Wetzels JF.

Med Oncol. 2011 Dec;28(4):1196-200. doi: 10.1007/s12032-010-9628-7. Epub 2010 Sep 24.

PMID:
20865462
14.

Quality of care in patients with chronic kidney disease is determined by hospital specific factors.

van Zuilen AD, Blankestijn PJ, van Buren M, ten Dam MA, Kaasjager KA, Ligtenberg G, Sijpkens YW, Sluiter HE, van de Ven PJ, Vervoort G, Vleming LJ, Bots ML, Wetzels JF; MASTERPLAN Study Group.

Nephrol Dial Transplant. 2010 Nov;25(11):3647-54. doi: 10.1093/ndt/gfq184. Epub 2010 Apr 9.

PMID:
20382963
15.

Toxicity of contrast media: an update.

ten Dam MA, Wetzels JF.

Neth J Med. 2008 Nov;66(10):416-22. Review.

16.

A lesbian identity disclosure assessment: ALIDA instrument.

van Dam MA.

J Homosex. 2008;55(1):166-82. doi: 10.1080/00918360802129451.

PMID:
18928050
17.

[Guideline 'Precautionary measures for contrast media containing iodine'].

van Dijk Azn R, Wetzels JF, ten Dam MA, Aarts NJ, Schimmelpenninck-Scheiffers ML, Freericks MP, Said SA, Geenen RW, Stuurman A, van Everdingen JJ.

Ned Tijdschr Geneeskd. 2008 Mar 29;152(13):742-6. Review. Dutch.

PMID:
18461890
18.

The dark side of the rings of Uranus.

de Pater I, Hammel HB, Showalter MR, van Dam MA.

Science. 2007 Sep 28;317(5846):1888-90. Epub 2007 Aug 23.

19.

Modeling low order aberrations in laser guide star adaptive optics systems.

Clare RM, van Dam MA, Bouchez AH.

Opt Express. 2007 Apr 16;15(8):4711-25.

PMID:
19532717
20.

Quasi-static aberrations induced by laser guide stars in adaptive optics.

van Dam MA, Bouchez AH, Le Mignant D, Wizinowich PL.

Opt Express. 2006 Aug 21;14(17):7535-40.

PMID:
19529119
21.

Multifactorial approach and superior treatment efficacy in renal patients with the aid of nurse practitioners. Design of The MASTERPLAN Study [ISRCTN73187232].

van Zuilen AD, van der Tweel I, Blankestijn PJ, Bots ML, van Buren M, ten Dam MA, Kaasjager KA, van de Ven PJ, Vervoort G, Vleming LJ, Ligtenberg G, Wetzels JF; MASTERPLAN study group.

Trials. 2006 Mar 30;7:8.

22.

A low density of 0.8 g cm(-3) for the Trojan binary asteroid 617 Patroclus.

Marchis F, Hestroffer D, Descamps P, Berthier J, Bouchez AH, Campbell RD, Chin JC, van Dam MA, Hartman SK, Johansson EM, Lafon RE, Le Mignant D, de Pater I, Stomski PJ, Summers DM, Vachier F, Wizinovich PL, Wong MH.

Nature. 2006 Feb 2;439(7076):565-7.

PMID:
16452974
23.

Measuring the centroid gain of a Shack-Hartmann quad-cell wavefront sensor by using slope discrepancy.

van Dam MA.

J Opt Soc Am A Opt Image Sci Vis. 2005 Aug;22(8):1509-14.

PMID:
16134845
24.

Rationale and design of the MASTERPLAN study: Multifactorial approach and superior treatment efficacy in renal patients with the aid of nurse practitioners.

Van Zuilen AD, Wetzels JF, Blankestijn PJ, Bots ML, Van Buren M, Ten Dam MA, Kaasjager KA, Van De Ven PJ, Vleming LJ, Ligtenberg G, Ligtenberg G; MASTERPLAN Study Group.

J Nephrol. 2005 Jan-Feb;18(1):30-4.

PMID:
15772920
25.

Performance of the Keck Observatory adaptive-optics system.

van Dam MA, Le Mignant D, Macintosh BA.

Appl Opt. 2004 Oct 10;43(29):5458-67.

PMID:
15508602
26.

Atmospheric turbulence characterization with the Keck adaptive optics systems. I. Open-loop data.

Schöck M, Le Mignant D, Chanan GA, Wizinowich PL, van Dam MA.

Appl Opt. 2003 Jul 1;42(19):3705-20.

PMID:
12868804
27.

Wave-front sensing from defocused images by use of wave-front slopes.

van Dam MA, Lane RG.

Appl Opt. 2002 Sep 10;41(26):5497-502.

PMID:
12224772
28.

Extended analysis of curvature sensing.

van Dam MA, Lane RG.

J Opt Soc Am A Opt Image Sci Vis. 2002 Jul;19(7):1390-7.

PMID:
12095207
29.

A thermally re-mendable cross-linked polymeric material.

Chen X, Dam MA, Ono K, Mal A, Shen H, Nutt SR, Sheran K, Wudl F.

Science. 2002 Mar 1;295(5560):1698-702.

30.
31.

Wave-front slope estimation

van Dam MA, Lane RG.

J Opt Soc Am A Opt Image Sci Vis. 2000 Jul;17(7):1319-24.

PMID:
10883985
32.

High-yield formation of giant bis(bicyclic) and crypt-tris(bicyclic) molecules under normal reaction conditions

Dam MA, Weitz A, Helgeson R, Ma B, Wudl F.

J Org Chem. 2000 Jun 30;65(13):3941-6.

PMID:
10866611
33.

The renal handling of pepsinogen A isozymogens in man.

Zwiers A, ten Dam MA, Crusius JB, Werter CJ, Pals G, Donker AJ, Meuwissen SG, ten Kate RW.

Clin Nephrol. 1994 Mar;41(3):153-8.

PMID:
8187358
34.

Renal handling of insulin and C-peptide in patients with non-insulin-dependent diabetes mellitus.

ten Dam MA, Werter CJ, Popp-Snijders C, Donker AJ, ten Kate RW.

Nephrol Dial Transplant. 1993;8(2):134-9.

PMID:
8384333
35.

Adrenoceptors on blood cells from patients with primary Raynaud's phenomenon.

Graafsma SJ, Wollersheim H, Droste HT, ten Dam MA, van Tits LJ, Reyenga J, Rodrigues de Miranda JF, Thien T.

Clin Sci (Lond). 1991 Apr;80(4):325-31.

PMID:
1851068
36.

Tubular reabsorption of pepsinogen isozymogens in man studied by the inhibition of tubular protein reabsorption with dibasic amino acids.

ten Dam MA, Zwiers A, Crusius JB, Pals G, Van Kamp GJ, Meuwissen SG, Donker AJ, ten Kate RW.

Clin Sci (Lond). 1991 Feb;80(2):161-6.

PMID:
1848169
37.

The effect of acute and chronic protein loading on urinary pepsinogen A excretion.

ten Dam MA, van Kamp GJ, Kok A, Meuwissen SG, Donker AJ, ten Kate RW.

Nephron. 1991;59(2):239-43.

PMID:
1956484
38.

Measurement of the glomerular sieving coefficient of endogenous proteins in man.

ten Dam MA, ten Kate RW, Werter CJ, van Kamp GJ, Meuwissen SG, Donker AJ.

Contrib Nephrol. 1990;83:47-52. No abstract available.

PMID:
2100721
39.

The recognition and treatment of hypervitaminosis A.

van Dam MA.

Nurse Pract. 1989 Aug;14(8):28, 30-1. Review.

PMID:
2671824

Supplemental Content

Support Center